Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baheal Pharmaceutical Group is a leading Chinese healthcare enterprise focused on the commercialization of pharmaceutical products and medical devices. The company operates a comprehensive health industry ecosystem, providing services ranging from brand operation and wholesale distribution to retail pharmacy and digital health solutions. Baheal is particularly known for its robust commercialization platform that helps global and domestic pharmaceutical companies navigate the Chinese market. Additionally, the group invests in innovative R&D and manufacturing, maintaining a diverse portfolio across multiple therapeutic areas including cardiovascular, oncology, and chronic disease management. Through its professional branding and extensive distribution network, Baheal serves as a vital link between advanced medical treatments and the Chinese healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Baheal Pharm.